Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2013 by Medical University of South Carolina
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Yubin Kang, Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT01410981
First received: July 13, 2011
Last updated: April 24, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)